{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-017081","form_type":"8-K","ticker":"GOVX","cik":"0000832489","company_name":"GeoVax Labs, Inc.","filed_at":"2023-06-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.389271+00:00","generated_at":"2026-06-14T03:23:17.352350+00:00","sec_items":["3.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"GeoVax gets Nasdaq extension to Dec 4, 2023 for $1 bid price rule","bullets":["Received Dec 9, 2022 deficiency letter for bid price below $1 for 30 consecutive days.","Nasdaq granted 180-day extension until December 4, 2023 to regain compliance.","Must close at or above $1 per share for 10 consecutive business days to comply.","If not met by deadline, Nasdaq will initiate delisting; company may appeal."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-017081","json":"https://secwatch.observer/filing/0001437749-23-017081.json","markdown":"https://secwatch.observer/filing/0001437749-23-017081.md","text":"https://secwatch.observer/filing/0001437749-23-017081.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/832489/000143774923017081/0001437749-23-017081-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/832489/000143774923017081/govx20230610_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T03:23:17.352350+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3ab3d0c3a17f87d7368e7b8a07f57eafdf1685d0","claim":"GeoVax Labs, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).","evidence_excerpt":"June 8, 2023, the Company received written notification from Nasdaq granting the Company’s request. The Company now has until December 4, 2023 to meet the Bid Price Requirement (the “Compliance Date”). The grant of the extension by Nasdaq has no effect on the listing of the Company’s shares, which will continue to be listed on the Nasdaq Capital Market under the symbol “GOVX.” If at any time prior to the Compliance Date, the bid price of the Company's common stock closes at, or above, $1.00 per share for a minimum of ten (10) consecutive business days Nasdaq will provide the Company with writt","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/832489/000143774923017081/0001437749-23-017081-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"extension granted"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}